Former President Jair Bolsonaro (PL) is showing signs of clinical stability and an improvement in renal function while remaining under intensive care at the DF Star Hospital in Brasília. The latest medical bulletin, released on Sunday, March 15, 2026, provided an update on his condition.
Bolsonaro has been hospitalized in the Intensive Care Unit (ICU) since Friday, March 13, 2026. The initial admission was prompted by a severe presentation of symptoms, leading to the diagnosis of bilateral bacterial bronchopneumonia.
His entry into the hospital unit followed a period of acute distress, characterized by:
- High fever
- Significant drop in oxygen saturation
- Profuse sweating
- Persistent chills
Despite the recent positive developments, the medical team has indicated that there is no immediate forecast for his discharge from the ICU. Physicians anticipate that the former president will require hospitalization for at least another seven days to ensure a full recovery.
Treatment adjustments reflect evolving condition
While Bolsonaro has achieved clinical stability and his kidney function has improved, the medical bulletin noted a new elevation in inflammatory markers within his bloodwork. This specific alteration prompted a swift response from the healthcare team.
In light of these changes, the treating physicians found it necessary to broaden the spectrum of antibiotics being administered. This adjustment aims to effectively target any persistent or evolving bacterial activity, optimizing his therapeutic response.
Intensive clinical support continues
The former president remains under comprehensive intensive clinical support, a critical component of his ongoing recovery in the ICU. This includes continuous monitoring of vital signs, organ function, and overall systemic responses to his treatment.
A significant focus of his care involves intensified physical therapy, encompassing both respiratory and motor exercises. Respiratory physiotherapy is crucial for clearing lung secretions and improving lung function affected by the pneumonia, while motor physiotherapy helps maintain muscle strength and prevents complications associated with prolonged bed rest.
These combined therapeutic approaches are vital in managing the complexities of severe bacterial bronchopneumonia and supporting his return to health.
Understanding bronchopneumonia and aspiration risks
Bronchopneumonia is a form of pneumonia that affects the bronchi and bronchioles, often spreading to surrounding lung tissue. It can be particularly serious, especially in individuals with other health considerations.
In Bolsonaro’s case, the condition was diagnosed as bacterial bilateral bronchopneumonia, specifically caused by the aspiration of stomach fluid. Aspiration pneumonia occurs when foreign materials, such as food, saliva, or stomach contents, are inhaled into the lungs, leading to infection.
Such episodes can be dangerous, potentially leading to severe inflammation and infection. Complications can include acute respiratory distress, as well as systemic effects such as impaired kidney function and elevated inflammatory markers, as observed in the former president’s clinical picture.
Prompt diagnosis and aggressive treatment with appropriate antibiotics are crucial in managing aspiration-related lung infections, alongside supportive care to manage associated systemic issues.
Road to recovery: anticipated hospital stay and follow-up
The medical team’s current assessment projects Bolsonaro’s hospitalization to extend for at least seven days, emphasizing the serious nature of his condition and the necessity for prolonged intensive monitoring. Recovery from severe bronchopneumonia, especially when complicated by aspiration, typically follows a gradual trajectory.
Patients often require extended periods of medical care to fully overcome the infection, regain lung capacity, and manage any secondary complications. The focus will remain on stabilizing his condition, eradicating the infection, and ensuring optimal organ function before considering discharge from intensive care.
Monitoring critical health indicators
The ongoing monitoring of inflammatory markers, such as C-reactive protein (CRP) and white blood cell count, is paramount in assessing the body’s response to infection and treatment. Elevated levels often indicate persistent inflammation or infection, guiding clinicians in adjusting antibiotic regimens and other interventions.
Similarly, renal function is a vital indicator, as kidney impairment can be a complication of severe infections or a side effect of certain medications. The reported improvement in Bolsonaro’s kidney function is a positive sign, suggesting a favorable response to current therapies and a stabilization of his physiological parameters. Managing these critical indicators effectively is central to his complex medical care.
